Here is a summary of the clinical note with the essential information:

**Cancer Type and Morphology:** Renal cell carcinoma (RCC) with multiple brain metastases.

**Cancer Stage:** Metastatic RCC to brain.

**Progression:** The patient's cancer has grown in the lungs, and there are new pulmonary metastases.

**TNM Staging:** Not explicitly stated.

**Prescribed Medications:** The patient is discharged with the following medications:

1. Docusate Sodium 100 mg PO BID
2. Morphine Sulfate 15 mg PO Q4H (prn pain)
3. Senna 2 TAB PO HS
4. Sertraline 100 mg PO DAILY
5. Tiotropium Bromide 1 CAP IH DAILY
6. Polyethylene Glycol 17 g PO DAILY (prn constipation)
7. Morphine SR (MS Contin) 15 mg PO Q12H
8. Metoprolol Tartrate 25 mg PO BID
9. Haloperidol 0.5-1 mg PO TID (prn agitation)
10. Haloperidol 1 mg PO HS

**Diagnostic Tests Conducted:**

1. CT head: No new brain metastases, stable vasogenic edema.
2. CT torso: Enlarging right renal mass, new pulmonary metastases, bilateral pleural effusions, and stable hypodense chest wall lesion.
3. CT pelvis: Sacral soft tissue without CT evidence of osteomyelitis, bladder wall thickening with intraluminal air and mild surrounding stranding.
4. RUE U/S: No deep vein thrombosis of the right upper extremity.
5. MRI Brain with contrast: No acute abnormalities or disease progression.
6. Blood cultures: Negative.
7. Urine culture: No growth.
8. Laboratory tests: Complete blood count, electrolyte panel, liver function tests, renal function tests, and others.

**Surgical Interventions Performed:**

1. Wound vac placement for sacral decubitus ulcer.

**Patient's Response to Treatment:** The patient's mental status mildly improved with IV fluids, antibiotics, and pamidronate. However, his thinking did not entirely return to normal. He was made DNR/DNI and transitioned to hospice care with a palliative focus.